Bicara Therapeutics
BCAX
#7214
Rank
C$0.80 B
Marketcap
C$12.10
Share price
-7.46%
Change (1 day)
-52.42%
Change (1 year)

EPS for Bicara Therapeutics (BCAX)

EPS in 2026 (TTM): C-$4.32

According to Bicara Therapeutics's latest financial reports the company's current EPS (TTM) is C-$4.45. In 2025 the company made an earnings per share (EPS) of C-$3.63 an increase over its 2024 EPS that were of C-$3.67.

EPS history for Bicara Therapeutics from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$4.3219.12%
2025C-$3.63-1.21%
2024C-$3.67